Marco Londei
2017
In 2017, Marco Londei earned a total compensation of $2.2M as Chief Medical Officer at ANAPTYSBIO, a 344% increase compared to previous year.
Compensation breakdown
| Bonus | $117,982 |
|---|---|
| Option Awards | $1,633,665 |
| Salary | $395,250 |
| Other | $3,960 |
| Total | $2,150,857 |
Londei received $1.6M in option awards, accounting for 76% of the total pay in 2017.
Londei also received $118K in bonus, $395.3K in salary and $4K in other compensation.
Rankings
In 2017, Marco Londei's compensation ranked 5,167th out of 14,666 executives tracked by ExecPay. In other words, Londei earned more than 64.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,167 out of 14,666 | 65th |
Division Manufacturing | 1,839 out of 5,772 | 68th |
Major group Chemicals And Allied Products | 547 out of 2,075 | 74th |
Industry group Drugs | 422 out of 1,731 | 76th |
Industry Pharmaceutical Preparations | 331 out of 1,333 | 75th |
Source: SEC filing on April 26, 2018.
Londei's colleagues
We found three more compensation records of executives who worked with Marco Londei at ANAPTYSBIO in 2017.